AgeX Therapeutics Inc. (AGE)
AMEX: AGE
· Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM
AgeX Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.82M | 7.08M | 4.44M | 808K | -9.44M | -3.46M | -5.39M | -2.68M | -3.29M | -2.76M | -2.44M | -2.62M | -2.71M | -2.16M | -1.96M | -2.48M | -1.99M |
Depreciation & Amortization | 17K | 103K | 80K | n/a | 25K | 33K | 33K | 32K | 33K | 33K | 33K | 33K | 33K | 33K | 32K | 33K | 33K |
Stock-Based Compensation | 956K | 2M | 1.05M | 23K | 53K | 503K | 40K | 35K | 70K | 114K | 209K | 198K | 239K | 263K | 272K | 286K | 178K |
Other Working Capital | n/a | -399K | -633K | n/a | n/a | 633K | -234K | 174K | -202K | 147K | 18K | 63K | -64K | -53K | -139K | 88K | -1.79M |
Other Non-Cash Items | n/a | -20.83M | -14.75M | n/a | n/a | 1.13M | 3.19M | 919K | 1.09M | 921K | 831K | 979K | 631K | 294K | 283K | 707K | -170K |
Deferred Income Tax | n/a | 909K | 734K | n/a | n/a | -734K | -175K | -199K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -437K | -196K |
Change in Working Capital | n/a | -901K | -468K | n/a | n/a | 468K | 433K | -127K | 230K | 372K | 127K | -338K | 168K | -78K | -516K | 192K | -482K |
Operating Cash Flow | -4.32M | -11.64M | -8.92M | n/a | -1.58M | -2.05M | -1.86M | -2.02M | -1.86M | -1.32M | -1.24M | -1.75M | -1.64M | -1.65M | -1.88M | -1.69M | -2.63M |
Capital Expenditures | n/a | -22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -466K | n/a | n/a | 466K |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 14K | -3K | n/a | -14K | n/a | n/a | n/a | -10M | n/a | n/a | n/a | n/a | 716K | n/a | n/a | -50K |
Investing Cash Flow | n/a | -8K | -3K | n/a | -14K | n/a | n/a | n/a | -10M | n/a | n/a | n/a | n/a | 250K | n/a | n/a | 416K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | -1.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1K | 41.91M | 6.6M | n/a | 2.73M | 2M | 2M | 2M | 11.5M | 1.5M | 1M | 2M | 1.5M | 1.25M | 2M | 1.5M | 2.5M |
Financial Cash Flow | 4.92M | 6.48M | 3.45M | n/a | 2.73M | 2M | 2M | 2M | 11.5M | 1.5M | 1M | 2M | 1.5M | 1.25M | 2M | 1.5M | 2.5M |
Net Cash Flow | n/a | n/a | n/a | n/a | 1.14M | -52K | 136K | -19K | -365K | 179K | -236K | 254K | -136K | -147K | 116K | -194K | 282K |
Free Cash Flow | -4.32M | -11.67M | -8.92M | n/a | -1.58M | -2.05M | -1.86M | -2.02M | -1.86M | -1.32M | -1.24M | -1.75M | -1.64M | -1.65M | -1.88M | -1.69M | -2.63M |